Clinical Trial Update: Glucagon Resistance in Patients With MASLD and T2DM [NA]

View source ↗

Summary

A recruiting clinical trial investigating glucagon resistance in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of Aarhus | Conditions: Metabolic Associated Fatty Liver Disease, Type 2 Diabetes (T2DM) | NA | Status: RECRUITING